Health Minister Mike Nesbitt has announced there will be no statutory public inquiry into the cervical screening scandal that affected 17,500 women in the Southern Health and Social Care Trust. The decision comes despite revelations that misread smear tests contributed to eight women developing cancer, two of whom have since died. The move follows the publication of a summary report by Professor Sir Frank Atherton, who concluded that a formal inquiry would be unlikely to provide further clarity beyond the six previous investigations already completed.
The scandal centres on failings at the Southern Trust’s laboratory between January 2008 and October 2021, when women received incorrect “all-clear” results due to underperforming screeners and inadequate management oversight. The Atherton report, published on 14 May 2026, represents the seventh major review of the crisis, commissioned in November 2025 to examine all previous work rather than launch a fresh investigation.
Minister Accepts Advice Against Public Inquiry
In a written statement to the Assembly, Minister Nesbitt explained his decision to accept Sir Frank’s recommendation against holding a statutory inquiry. The Minister stated:
“I asked Sir Frank to consider whether a statutory public inquiry might provide additional significant insight and assessment to the findings already made in relation to questions of responsibility and to the future safety of this important population screening programme. Sir Frank concluded that while there have been significant failings, a statutory public inquiry is highly unlikely to provide any further clarity. I accept these findings and advice from Sir Frank. A Statutory Public Inquiry is a means to an end, that end being answering key questions. I believe those answers have been addressed as far as that is possible. We know what happened, why it happened, who was responsible and what has been done to try to ensure it never happens again.”
The Minister acknowledged the disappointment this decision would cause to campaigners, particularly the Ladies with Letters group which represents the thousands of women recalled for testing. He added:
“I acknowledge that this has been a particularly difficult and challenging time for the women and their families who have been impacted by cervical cancer. I want to pay tribute to their determination and acknowledge the profound effect these events have had on their lives. I have listened to many of their personal stories and am deeply sorry to hear that for some women, mistakes were made during the cervical screening pathway and programme.”
Previous Reports Catalogued Systemic Failings
Sir Frank’s assessment examined a catalogue of failings previously identified across six separate reports, including:
- The Royal College of Pathologists’ report (October 2023) which found ‘persistent underperformance’ by cytology staff
- The Cervical Cytology Review outcomes (December 2024) covering 17,425 women
- A Serious Adverse Incident review involving 12 patients with cervical cancer
- An NHS England review of Public Health Agency quality assurance arrangements
The reports established that staffing levels in the Southern Trust laboratory were insufficient to manage workloads, leading to excessive overtime and declining quality. Management failed to monitor performance trends over several years, instead reviewing individual screeners in isolation. The consequences proved devastating: eight women whose tests were misread subsequently developed cancer, including Lynsey Courtney (aged 30) and Erin Harbinson (aged 44), who both died.
Professor Sir Frank Atherton stated:
“I hope this summary report helps to explain the historic failures in the Cervical Screening Programme delivered by the Southern Health and Social Care Trust, and provides reassurance that the changes which have been made will ensure delivery of a safe, effective service for women in Northern Ireland in the future.”
Systemic Changes Implemented
The Department of Health highlights that significant reforms have already been implemented since the failings were exposed. Cervical screening is no longer performed at the Southern Trust; instead, a single regional laboratory service was established at Belfast Health and Social Care Trust in November 2024. All screening now uses primary HPV testing—introduced in December 2023—which is more reliable than the cytology-based system that failed the affected women.
Minister Nesbitt confirmed that all recommendations to strengthen accountability and quality assurance are either fully implemented or in progress. He stressed that the current programme differs fundamentally from the one that operated during the scandal years:
“Screening programmes are complex by nature, which is apparent in all reports commissioned and published to date. It is also important to state that screening is not the same as a diagnostic assessment. Screening inherently is more open to false negative conclusions. Moving to HPV screening is fundamentally different to the one delivered during the period in question and designed to decrease the number of false negatives.”
Unanswered Questions and Campaigner Concerns
Despite the Minister’s assertion that “we know what happened,” questions remain about whether accountability has been fully established. The Ladies with Letters campaign group—formed by women who received recall letters—has consistently argued that only a statutory public inquiry can deliver the transparency and accountability needed to restore public confidence. While the Minister noted he asked Sir Frank to meet with campaign representatives before finalising his terms of reference, the decision to forgo a public inquiry leaves some affected families without the formal legal scrutiny they had sought.
The review process itself has taken nearly three years since the initial Royal College report in October 2023, with some women dying before seeing conclusions published. The Department has not detailed what specific disciplinary or professional consequences have followed for those responsible for the management failures, beyond noting that one screener was suspended and conditions of practice placed on another by the Health and Care Professions Council.
Limits of Administrative Review
The Atherton report’s conclusion—that a statutory inquiry would add no value—rests on the premise that seven separate investigations have already established the facts. However, critics may note that none of these previous reports had the legal powers of a statutory inquiry to compel witness testimony under oath or examine documents with full legal authority. The Minister’s acceptance that answers have been addressed “as far as that is possible” suggests there may be limits to what can be achieved through administrative review alone.
Furthermore, while technical improvements (HPV testing and centralised laboratories) address the scientific failings, questions persist about the cultural and governance issues that allowed underperformance to continue for 13 years without detection or intervention.
Next Steps for Implementation
The Minister has tasked officials with ensuring all recommendations from Sir Frank and previous reports are fully implemented. Women aged 25-64 continue to be invited for screening, now using the HPV primary testing method which Northern Ireland adopted later than other UK regions.
Key questions remain for stakeholders to consider:
- Without a statutory inquiry’s legal powers, can full accountability for management failures be truly established?
- How will the Department monitor the Belfast centralised laboratory to ensure staffing and quality issues do not recur?
- What specific redress or support mechanisms remain available for the eight women who developed cancer and the families of those who died?
- Can public confidence in the screening programme be restored while relying on administrative rather than judicial scrutiny of past failings?
- How will the Department prevent similar “isolated” performance reviews that fail to spot trends across years, as identified in the Southern Trust case?
The full Atherton report and the Minister’s written statement are available on the Department of Health website.